RECENT MYOCARDIAL INFARCTION

Clinical trials for RECENT MYOCARDIAL INFARCTION explained in plain language.

Never miss a new study

Get alerted when new RECENT MYOCARDIAL INFARCTION trials appear

Sign up with your email to follow new studies for RECENT MYOCARDIAL INFARCTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New blood thinner CG-0255 faces off against plavix in early trial

Disease control Recruiting now

This Phase 1 study compares a new investigational drug, CG-0255, to the standard blood thinner Plavix in 136 healthy adults aged 18-55. The goal is to see how the body absorbs and processes each drug and how well they prevent blood clotting. Participants will receive either CG-02…

Matched conditions: RECENT MYOCARDIAL INFARCTION

Phase: PHASE1 • Sponsor: Shanghai CureGene Pharmaceutical Co., Ltd. • Aim: Disease control

Last updated Jun 22, 2026 11:59 UTC

RECENT MYOCARDIAL INFARCTION

Get alerted when new RECENT MYOCARDIAL INFARCTION trials appear

New blood thinner CG-0255 faces off against plavix in early trial